Home » Dispatches »

SoHum Brings CBD-Rich Seeds to L.A.

SoHum-at-cup

We got an update from Lawrence Ringo of SoHum seeds, whose booth at the High Times event in L.A. last weekend featured seeds from three CBD-rich strains: his original Sour Tsunami, a Sour Tsunami-Harlequin cross (“Harle-Tsu”) and a Sour Tsunami-Cannatonic cross (“Canna-Tsu”).

Back at the ranch, Ringo told us, he’s growing out two new strains — “Swiss Gold,” a clone of which he purchased at Organicann in Santa Rosa, and ACDC, which William Courtney, MD, gave him saying, “Grow billions of seeds. The world’s going to need them.” Courtney told Ringo that a lab had found ACDC to have a 22:1 CBD-to-THC ratio; and that it was a Sativa-dominant plant grown for hemp in France; and that it was being grown on 13 hectares in Luxembourg for use in a clinical trial of its juiced leaves and flowers.

Ringo describes the Swiss Gold as “a pure Indica, short and fat.” He grew it out in a 20-gallon bucket to observe its traits. “Everything that I grow the first year goes into a bucket,” he explains, “because I don’t want to waste this primo ground that I’ve spent years building up.” It was tested by Pure Analytics and found to contain 8% CBD, 2% THC.

His ACDC was only a foot tall as of Feb. 12. When it’s two feet he’ll take cuttings and speed up their budding so they can be tested while the mother plants continue to grow.

At the High Times event in LA interest in CBD-rich herb was strong and foot traffic heavy, Ringo reported, but SoHum was directly across from a DJ box that was loud from 50 yards away. “A lot of people wanted to talk but couldn’t because we were getting pounded by the music,” Ringo lamented. “Five or six people were in wheelchairs and they never came back.” The booth cost $3,000 —$800 more than he’d ever paid for space at a trade show.

Report from Pure Analytics

Samantha Miller of Pure Analytics tested the two sets of samples from Ringo’s recent crosses. Her comments follow:

Group 1

All samples received were freshly harvested cannabis seedling samples from three different populations of seed stock, Swiss Gold x Sour Tsunami, Cannatonic (2:1) x Sour Tsunami and Harlequin x Sour Tsunami. All samples were dried in the laboratory over the course of eight days. All dried samples were analyzed for cannabinoid potency and profile to determine THC vs.C BD dominance, approximate ratios and distribution of those ratios.

The Swiss Gold x Sour Tsunami group of seedlings consisted of thirteen individual samples. Of those thirteen, six seedlings were found to be CBD-dominant, supporting the prediction that progeny from the cross would have a CBD-dominance frequency of 50%. Of the 6 CBD-dominant samples isolated, two were found to have a cannabinoid profile consisting of very high relative CBD levels with only a very small relative amount of THC. Both a female and male were isolated, #3 and C from this high relative CBD group. The remaining four CBD-dominant seedlings were all found to possess a 2:1 ratio of CBD:THC.

The Cannatonic x Sour Tsunami seedlings consisted of a group of 8 individual samples. Five of these eight were found to be CBD-dominant, supporting the hypothesis that the progeny from the cross would have a CBD-dominance frequency of 50%, or one out of every two seeds. Of the five CBD-dominant seedlings, one was found to have a cannabinoid profile almost entirely CBD, with only a small relative amount of THC. The remaining four CBD-dominant samples were found to be 2:1 CBD:THC ratio seedlings.

The Harlequin x Sour Tsunami seedlings consisted of a group of nine seedlings, where seven were found to be CBD-dominant. Of the seven CBD-dominant seedlings, three were found to have very high relative CBD-levels, and the remaining four seedlings were found to possess a 2:1 ratio of CBD:THC. This seed stock would represent a unique offering with 3 of every 4 seeds providing a CBD-dominant plant. Additional analysis of a larger sample population should be performed to validate this finding to support the potential claim of 75% CBD-dominance frequency.

Group 2

Seedling samples from two populations of seed stock, Harlequin x Sour Tsunami and Swiss Gold x Sour Tsunami, were analyzed for cannabinoid potency and profile to determine THC vs. CBD dominance, approximate ratios and distribution of those ratios.

Three samples of Harlequin x Sour Tsunami were analyzed. Two of the three were found to be CBD-dominant and both of these were found to have a 2:1 CBD:THC ratio.

Two samples of Swiss Gold x Sour Tsunami were analyzed and were found to be THC-dominant in both cases.

Support O’Shaughnessy’s

"From each according to their ability, to each according to their need." 

Our Entourage

Best newspaper in America Dr. Tod – The Movie The Society of Cannabis Clinicians was formed as a project of the California Cannabis Research Medical Group in the Autumn of 2004. Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD) and other components of the Cannabis plant. News and political analysis Dr. Lester Grinspoon, M.D. is Associate Professor Emeritus of Psychiatry at Harvard Medical School. Dr. Grinspoon was senior psychiatrist at the Massachusetts Mental Health Center in Boston for 40 years. Moving Sustainable Medicines Forward Consultant Newhead News Political allies Whole plant medicinal extracts Law Office Great artwork, incisive politics Omar CBD specialists

O’S Available Here

O’S First E-Book – Available Now!

Recommended Reading

Double-click to edit content...

Plugs

Prop 215 Ballads – Fred Gardner’s CD Medical Cannabis Videos
"Our imagination is stretched to the utmost, not, as in fiction, to imagine things which are not really there, but just to comprehend those things which are there."
—Richard Feynman

The Second Column

The Shortage of Black Doctors

Damon Tweedy, MD

African Americans account for 13% of the population and five percent of US physicians. The May 17 NY Times included a terrific piece by Damon Tweedy, MD, a psychiatrist affiliated with Duke …

‘Lucky, Jr’ Makes the Cover of Time!

Photo-illustration by Brobel Design for TIME. Mouse: Getty, Lighter, Joint, Smoke: iStockphoto

The May 25 Time Magazine cover photo is of a white rodent smoking a joint —an offspring of Lucky, the Lab Mouse, who we interviewed for O’Shaughnessy’s in 2010.  The Time story by …

Study Looks at the Contact High

photo: dailytech.com

May 14    A group of addiction specialists from Johns Hopkins University have proved that second-hand smoke from marijuana can have an effect on those who inhale it. …

Neurology With a Vengeance

kennedy-hospital-mom

May 5 2015  Child Protective Services —with backing from a prejudiced medical establishment— has moved against so many American parents that an organized nationwide opposition has formed. An SCC member forwards this …

A New Study From Drs. Nelson and Haggard

Willie and Merle

April 27    Cannabis as an alternative to alcohol and pharmaceutical drugs is the theme of a new study from musicologists at the University of Texas-Bakersfield. Prohibition was costly to Willie Nelson and …

A Write-off for Causing Bladder Cancer

Takeda Pharmaceuticals Actos diabetes pills are arranged next to a bottle of the medicine for an illustration at C O Bigelow Pharmacy in New York, U.S., on Thursday, Oct. 25, 2007.  Takeda Pharmaceutical Co., Japan's largest drugmaker, may forecast its biggest jump in full-year profit in six years on sales of the Actos diabetes pill it counts on for almost a third of revenue. Photographer: JB Reed/ Bloomberg News

By O’S News Service April 28, 2015    Some 9,000 people who developed bladder cancer after using Actos —a diabetes drug in pill form— have been offered a $2.4 …

Ethan Russo, Local Hero

Russo : VIMEA

 April 22 From O’S News Service   Ethan Russo, MD, a mild-mannered neurologist, has lived inconspicuously for almost a decade on Vashon Island, a ferry ride from Seattle. Russo’s secret identity was …

FDA Warns CBD Scammers

FDA Warning

Dr. Rik Musty, the first U.S. researcher to investigate CBD, alerted us to this item posted on the US Food and Drug Administration website, March 3, 2015: Warning Letters …

Big PhRMA Seeks Stoner Cred

Kevin Nealon

The comedian Kevin Nealon is pushing a blood thinner called Xarelto, aka Rivaroxaban, which is made by Bayer, FDA-approved and distributed by Janssen. Xarelto can cause a type of internal bleeding …

Items You Might Have Missed…

Musicophilia

From O’S News Service April 13, 2015  Deadly Drug Allergies    Most fatal allergy attacks in the U.S. are caused not by insect stings or food, but by …

Mechoulam’s Democratic Perspective

Mechoulam preface

April 8, 2015   Istvan Ujvary sent in  this essay published in 1973 by Raphael Mechoulam, commenting: “I thought you would like the last sentences of the attached preface …

Other Products, Other Labs (Good Old Costco)

toscano01

By O’S News Service   Ever since we heard Raphael Mechoulam associate olive oil in the Southern European diet with significantly reduced cancer rates, we have been on the look-out …

Addiction Specialists are the Drug Warriors’ “Brain Trust”

THM Resigns

April 8, 2015  Dr. Hergenrather forwards “some biased stories coming out of Massachusetts,” with the observation: “As soon as I see a ‘drug abuse’ background in a naysayer, …

Remembering Murphy Brown

phot by Damon Winter/NYT

By O’S News Service April 6, 2015   Candy Bergen has just published a memoir called “A Fine Romance.” According to the New York Times, the actress “parses the nation’s …

Senate Bill Would Move Cannabis to Schedule II

Official Portrait

Hanya Barth, MD, forwards a press release announcing a Senate bill introduced March 10 —the “CARERS” Act— that has been endorsed by leading drug policy reform groups, including Americans for Safe Access …

Dr. Malka Joins KPIX Attack on 420MD

Screen shot 2015-03-17 at 9.07.35 AM

By O’S News Service March 17   KPIX, the Bay Area’s CBS affiliate, is covering the prosecution of a “potdoc” chain called 420MD. Read the background here.  Last night …

NYPD Chief Says Marijuana Causes Murder

Bratton Oregano Platt

 March 9   A front-page article  in the New York Times was given a rare two-sentence headline.   Back in November 2014 Mayor Bill de Blasio and Police …

Phrenology in the 21st Century

marijuana-brain

March 12, 2015   Nancy Sajben, MD, forwards a meant-to-frighten story from the Daily Mail based on a paper just published in Hippocampus by psychiatrists at Northwestern University.  The headline and subhead: Smoking …

Pill Pushers Preying on Women

abilify

In 2010 Julie Holland, MD published an excellent anthology called “The Pot Book.” Lester Grinspoon, MD, and SCC president Jeffrey Hergenrather, MD, were among the clinicians and researchers who …

Tylenol kills, Statins ‘associated with’ diabetes (ho hum)

tylenol

This snippet is from the British Medical Journal 3/3/15:  “…The true risks of taking the drug [paracetamol in England,  acetaminophen in the US, brand name Tylenol] may have been underestimated, …